FDA Public Workshop – Using Patient Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond

The Food and Drug Administration (FDA), along with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), is announcing the following public workshop entitled “Using Patient Preference Information in Medical Device Regulatory Decisions:  Benefit-Risk and Beyond”. The purpose of the public workshop is to discuss and explore potential applications, challenges, and opportunities of using Patient Preference Information.

INTRODUCTION

Patient Preference Information (PPI) is increasingly being used in regulatory decision making for medical devices. This workshop will provide a forum to engage key stakeholders, including patients, researchers, regulators, payers, and the life sciences industry, to discuss and explore potential applications, challenges, and opportunities of using PPI across the healthcare ecosystem. Topics that will be discussed include the value of including PPI in different settings, case studies highlighting the use of PPI, and methodologies for collecting PPI. 

WEBCAST

The public workshop will be webcasted live and the link will be posted on the website for viewing after the workshop.

REGISTRATION

Please visit the ISPOR website to register for the pre-event webinar and workshop:  https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-fda-summit-2020

RESOURCES

Follow this blog